Back to Our Team

Dr. Andy Anantha

Head of CMC
Dr. Andy Anantha, Head of CMC, is the President of AVA Pharma Consultants and has over 30 years of experience in successfully conducting research and development in bio-pharmaceutical organizations and companies in the CMC space for both NCEs and Generics.

Prior to AVA Pharma Consultants, Dr. Anantha was most recently the Vice President of Pharmaceutical Development & Quality at vTv Therapeutics. In this role, he was responsible for complete CMC development and regulatory filings. Several lead candidates were taken to IND, Phase 1, 2 and Phase 3 stage. Before vTv Therapeutics, Dr. Anantha was the General Manager of Research at Torrent Pharma, India on both NCE and ANDA fronts. Responsibilities included API, formulation and Analytical development activities and Regulatory filings. Dr. Anantha has spent 30 years in the bio-pharmaceutical industry, including serving as a Manager/Principal Scientist at Wyeth Research for 9 and 1/2 years. of In this role, in addition to research and development in Analytical and Quality, he led interdisciplinary team of scientists on projects from CMC side. Other experience includes 7 years in the Generics research and development area at G & W labs.

​Dr. Anantha is an author of several peer reviewed publications and was a secretary and is a member at the API manufacturing division of American Association of Pharmaceutical Sciences.
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
CONTACT US
info@bantampharma.com
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram